[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Andre_AGTC Andre-ACGTAndre-ACGT posts on X about $xene, $abvx, $krys, $mdgl the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Social category influence stocks XXXXX% finance XXXXX% countries XXXX% currencies XXXX% cryptocurrencies XXXX% technology brands XXXX% automotive brands XXXX%
Social topic influence $xene #1, $abvx #16, $krys #1, $mdgl #3, $rvmd #1, $bbio #2, $prax #6, $crnx #2, $axsm #1, $mirm #1
Top accounts mentioned or mentioned by @physioo @bioinvestor24 @monacobiotech @saicharanaitha @lpessa7654 @bearsbounce @maximusholla @biopharmiq @17catspaw @pharmdca @andersresearch @joserestonva @bowtiedbiotech @wallstsai @garywhi13830766 @pacha8x @deepsouthdoctor @tommy59737243 @kingachillese @piratewaffle
Top assets mentioned Xenon Pharmaceuticals Inc (XENE) Krystal Biotech, Inc. Common Stock (KRYS) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Revolution Medicines, Inc. Common Stock (RVMD) BridgeBio Pharma, Inc. Common Stock (BBIO) Praxis Precision Medicines, Inc. Common Stock (PRAX) Crinetics Pharmaceuticals, Inc. (CRNX) Axsome Therapeutics, Inc (AXSM) Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Kymera Therapeutics, Inc. Common Stock (KYMR) Viridian Therapeutics, Inc. Common Stock (VRDN) Eli Lilly and Company (LLY) Scholar Rock Holding Corporation Common Stock (SRRK) Viking Therapeutics, Inc (VKTX) Nuvalent, Inc. Class A Common Stock (NUVL) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Wave Life Sciences Ltd. Ordinary Shares (WVE) Neurocrine Biosciences, Inc. (NBIX) Janux Therapeutics, Inc. Common Stock (JANX) Intra-Cellular Therapies Inc. (ITCI) Blueprint Medicines Corporation (BPMC) Vera Therapeutics, Inc. Class A Common Stock (VERA) Terns Pharmaceuticals, Inc. Common Stock (TERN) Dyne Therapeutics, Inc. Common Stock (DYN) Alnylam Pharmaceuticals, Inc. (ALNY) Catalyst Pharmaceutical Inc. (CPRX) Corcept Therapeutics Inc. (CORT) uniQure N.V. (QURE) Mineralys Therapeutics, Inc. Common Stock (MLYS) Acadia Pharmaceuticals Inc. (ACAD) Merus N.V. Common Shares (MRUS) Synthetify (SNY) Vir Biotechnology, Inc. Common Stock (VIR) Cytokinetics Inc. (CYTK) Cidara Therapeutics, Inc. (CDTX) AstraZeneca PLC (AZN) Adverum Biotechnologies, Inc. Common Stock (ADVM) TG Therapeutics, Inc. (TGTX) Soleno Therapeutics, Inc. Common Stock (SLNO) Amazon.com, Inc. (AMZN) Tesla, Inc. (TSLA) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Amgen, Inc. (AMGN) Novartis AG (NVS)
Top posts by engagements in the last XX hours
"Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS"
X Link 2025-09-30T14:34Z 6242 followers, 19.2K engagements
"@monaco_biotech @bearsbounce $BLTE Good find Monaco I am with you here at XXX. Who would think oral Ophthalmology drug would work Agree Darvin global is a gem - supper highly concentrated And the hit X BOs - $VRNA $MRUS I guess $ABVX will soon join them"
X Link 2025-12-12T13:39Z 6243 followers, 4573 engagements
"@17catspaw Agree. I even forgot $CDTX bc I didn't have a position in it"
X Link 2025-12-12T14:43Z 6243 followers, XX engagements
"@Maximus_Holla Does it mean the data are comming before Dec 18"
X Link 2025-12-12T18:45Z 6243 followers, XXX engagements
"$MLYS at $XX $NKTR at $XX Both expect good news soon MLYS pre NDA meeting NKTR legal settlement w/ $LLY"
X Link 2025-10-01T15:00Z 6235 followers, 3537 engagements
"$KYMR STAT6 is the only specific transcription factor in the IL-4/13 pathway blocking TH2 inflammation Key catalysts Ph1b AD data in Q4"
X Link 2025-10-05T16:14Z 6235 followers, 6780 engagements
"$JANX vs $VIR (NP) VIR in PSMA is interesting to follow"
X Link 2025-10-11T15:12Z 6229 followers, 2905 engagements
"Sounds easy First in class with unique MOA and large TAM I had XX aquisition in my port in the last 2.5y and most of them fit this description From my current holding IMO $XENE $MDGL $KRYS $BBIO $RVMD $NKTR fit these requirements"
X Link 2025-10-15T00:59Z 6236 followers, 9064 engagements
"$VRDN XXXXX hello +75% since my entry in May. The chart is straight line - constant accumulation Enrollment complete in two ph3 TED trails. Data in h1'26 VRDN-003 COM patent granded. IP until 2041 Veligrotug BLA Nov'25 Mid-2026 launch if approved under Priority Review"
X Link 2025-10-15T22:05Z 6234 followers, 3038 engagements
"$VRDN Jefferies w XX PT based on competitor $RHHBY not competitive results Enrolment in both trails completed with data in h1'25 TED market is 4B or 8B if early stages are included $VRDN MC is 2B with 560M cash"
X Link 2025-10-18T14:16Z 6235 followers, 3599 engagements
"$ADVM (NP) aquired with CVR 2x of the cash per share. It must be a record CBR to share ratio Bought some $FDMT for $XX at open. It may run up in sympathy"
X Link 2025-10-24T13:58Z 6236 followers, 3385 engagements
"$NBIX $2.1B cash profitable looking to grow the business. $XENE fits well but too big at 3.3B $PRAX are even expensive at 5B MC $VTYX 540M will work for them BTW why VTYX didn't raise capital after the cardio data Just asking no speculations"
X Link 2025-10-28T22:55Z 6236 followers, 4825 engagements
"$IMRX IMO a stock to buy and forget for a few years. The same approach I took with $RVMD in low 20s now at XX L1 in PDAC with 9-month OS rate of XX% above XX% historical GnP benchmarks. Plus XX% PFS at X months All that is precursor for success"
X Link 2025-10-31T12:59Z 6236 followers, 5342 engagements
"@Quantumup1 Agree. I still like more $RVMD bc is more advanced plus RAS is a platform $IMRX has different pathway - MAPK and the pipeline is not so deep"
X Link 2025-10-31T13:17Z 6236 followers, XXX engagements
"$VRDN BLA for TED submitted with priority review. Potential launch in mid 2026 SQ data for both ph X trails accelerated to Q1 and Q2 Cash 888M net loss 34M"
X Link 2025-11-05T13:47Z 6235 followers, 3292 engagements
"$CRNX vs $TGTX pipeline"
X Link 2025-11-08T15:43Z 6228 followers, 5077 engagements
"$KURA Clean label (no QTc Boxed Warning) gives a clear edge to $SNDX. It increases the # of pts and removes the cardio testing ➡ IMO it's a green light KURA to be aquired I wrote just the same about $ITCI in Dec '24. Aquired in Jan'25 Let's see if the history repeats"
X Link 2025-11-14T16:32Z 6234 followers, 3591 engagements
"Avoro $MDGL #3 -X% (my #1) $KRYS #5 +4% (my #2) $QURE #12 +23% (my #20+) $XENE #13 +0% (my #4)"
X Link 2025-11-15T00:08Z 6236 followers, 2015 engagements
"I love biotech $SPI - XXX% from top; +14.6% YTD $QQQ -XXX% from top; +19.1% YTD My account ATH +220.6% YTD All my top dogs are at ATH or close to $MDGL $KRYS $AXSM $XENE $RVMD $BBIO $$MIRM $VTYX $PRAX $NKTR $NUVL $ABVX Plus X top BOs $ITCI $BPMC $VRNA No jinx intended 😉"
X Link 2025-11-15T17:16Z 6230 followers, 6678 engagements
"$RVMD This tip keep aging well X in XXX mo and counting It was one of the best low risk play Still 5mo until expiration enough to cover ph3 data and JMP conference IMO good platform aquisition. Pricy but worth it"
X Link 2025-11-18T18:46Z 6235 followers, 2856 engagements
"This didn't age well. Already a bit in red on these trades. I thought I am doing a killing in a down market Oh well I should keep buying what I know a bit better like $ABVX or $VTYX or $VRDN"
X Link 2025-11-20T22:47Z 6236 followers, 5864 engagements
"$MIRM MC 3.6M /Rev / Profit/ Cash Q3 / 133M/ 3/ 378M Q2 /128M / -6M/ 322M Q1'25/ 112M/ -15M/ 299M Q4/ 99M/ -124M / 293M Q3/ 90M/ -103M/ 294M Q2/ 78M/ -102M/ 286M PSC ph3 data q2'26 PBC ph3 data h1'27 Projected '25 rev 500-510M"
X Link 2025-11-21T20:52Z 6228 followers, 1892 engagements
"Keeping w/ the tradition - XX weeks in a row the trading accont at ATH Almost all top stocks at ATH Comments $PRAX got hit by a short report. Let's see if Mon call can bring some clarity $MIRM soft Q3 stopped the momentum $XENE rump up to ph3 data $NKTR temp. consolidating"
X Link 2025-11-21T22:23Z 6236 followers, 3247 engagements
"$BBIO Cantor with XXX PT That's 19B MC at estimated 8B peak sales I have 20B target which is 2.x the projected revenue"
X Link 2025-11-22T22:26Z 6228 followers, 5221 engagements
"@DueDoctor Could we end up in $SWTX scenario The aquisition price was -XX% below the rumored BO price. Or $CYTK Oh well it was a different story"
X Link 2025-11-23T20:07Z 6236 followers, 3380 engagements
"$VRDN TED BLA and potential launch in 2026 Interesting that Tuist model 1.6B by 2034 in anti-IGF-1R platform"
X Link 2025-11-24T15:30Z 6236 followers, 1483 engagements
"$VRDN This trade is aging well - 2.5x return so far. And still the main catalysts- BLA submission and FDA PDUFA date are ahead of us. IMO we will see 30+ in mid Jan"
X Link 2025-11-24T15:37Z 6236 followers, 1527 engagements
"@Craigster771 $VIR - stopped following them early this year. May revisit if $JANX data are very good"
X Link 2025-11-24T18:23Z 6228 followers, XXX engagements
"$MDGL $ABVX Two stocks trading identically since the beginning of November Both up XX% in X weeks on strong volume Let's see what it means The easy explanation is BO rumors"
X Link 2025-11-25T02:16Z 6235 followers, 3790 engagements
"@SaicharanAitha @Anders_Research $VTYX It was a fabulous run from X to XX. So taking profit is natural Make sure to buy something promising with the proceeds. May I recomend to park the cash in $XENE"
X Link 2025-11-25T22:12Z 6236 followers, XXX engagements
"@SaicharanAitha @Anders_Research Currently $XENE is my 3rd position (after $MDGL and $KRYS) and I added yesterday if that can give you a courage to get back🙂"
X Link 2025-11-25T22:36Z 6230 followers, XXX engagements
"$JANX this ticket is looking better and better +50% already. Looking for another +50% with the data at least the Dec option traders think so Good that mCPRX data are first bc I am not very confident in EGFR trail"
X Link 2025-11-26T02:21Z 6236 followers, 8155 engagements
"$XENE (MC 3.4B) $PRAX (MC 4.7B) 2025 AES Dec 5-9 in Atlanta Both with 7-8 presentations in epilepcy Both will present OLE data in FOS. Different MOA"
X Link 2025-11-28T13:56Z 6236 followers, 1369 engagements
"Top near term binary events My interest is in $BBIO $RVMD $IDYA $SRRK $BHVN MDD is a toss-up but worth playing"
X Link 2025-12-01T13:52Z 6228 followers, 10.1K engagements
"If $NVO aquires $SRRK it will restore my confidence in this badly managed company"
X Link 2025-12-03T16:27Z 6236 followers, 5237 engagements
"$CRNX Start Ph 1/2 in metastatic or locally advanced SST2 positive neuroendocrine tumors and other SST2 solid tumors. It's nonpeptide drug conjugate (NDC) modular platform for endocrine and endocrine-related tumors"
X Link 2025-12-03T18:47Z 6234 followers, 1913 engagements
"$ABVX I may disappoint some here but it looks like a $CYTK sequel. Hope I am wrong and some BP aquires them soon or we see low XX (last capital raise)"
X Link 2025-12-03T21:09Z 6234 followers, 25K engagements
"I am getting regular calls from Fidelity They say - my accont is not diversified (70% in biotech) and my top X are above the recommended max allocation My answer is - diversification is a mother of mediocracy Next time they call I will refer them to Stanley Druckenmiller"
X Link 2025-12-04T01:09Z 6229 followers, 4202 engagements
"$MLTX $XX holla. Cash 380M; EV 640M If allowed to file NDA in HS the stock may double. Worth the risk $AVTX Soon $XX holla. Cash 111M; EV 180M Another HS contender with Ph2 data in mid 2026 TAM is projected 8B in 2034 $UCB is dominant player"
X Link 2025-12-04T18:48Z 6236 followers, 2089 engagements
"Single study is enough for approval Very positive for $AXSM (ADA) $PRAX (ET) $MLTX (HS)"
X Link 2025-12-04T20:09Z 6236 followers, 5823 engagements
"$BBIO ACH ph3 data in q1'26"
X Link 2025-12-04T20:49Z 6228 followers, 1972 engagements
"$PRAX SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) early stoped for efficacy It's NaV channel so we may see some sympathy in $XENE"
X Link 2025-12-04T22:18Z 6236 followers, 5301 engagements
"$ABVX Good point why $ABBV isn't a potential aquirer. IMO nobody currently is before the maintenance data due to some concerns about elevated miR-124 level. Could it bring surprises in long term like cardiac issues Long-term safety data are needed before any BO"
X Link 2025-12-05T04:58Z 6235 followers, 10.2K engagements
"$ABEO first patient treatment with RDEB It company milestone Reminder- each treatment is 3.1M so easy to became profitable in short term Stayed tuned for the next two ERs I believe double digit by mid 2026"
X Link 2025-12-08T13:41Z 6234 followers, 5044 engagements
"$GPCR Loking into GPCR data (oral GLP1) I start thinking that $PFE made another strategic mistake BTW selling GPCR at 5B mc is like missing half of the potential profit $MTSR got 9B for long acting peptide injection"
X Link 2025-12-08T15:22Z 6235 followers, 3797 engagements
"$XENE Epilepcy OLE data Monthly reductions in seizure frequency of XXXX% among participants treated for XX months with XX% achieving X year of seizure freedom"
X Link 2025-12-08T22:52Z 6235 followers, 1512 engagements
"$BHVN MDD ph2 data with Kv7 activator anytime now (expected q4'25) $XENE had mixed ph2 data with the same target last year in general positive. The bar is set so BHVN shoukd beat that or"
X Link 2025-12-09T14:11Z 6236 followers, 4943 engagements
"$BHVN pipeline To save cash they put on hold many programs. Those that remain active: Kv7 activator- FOS and MDS Myostatin - SMA IgG degrader - Graves' IgA degrader- IgAN I used to like them. Now I hold 5c and 7.5c Jan'26 and Jan'27"
X Link 2025-12-09T14:49Z 6236 followers, 3023 engagements
"Capital raise - all upsized small discount - strong demand $KYMR 500M -602M @ $XX /-1% $GPCR 500M -650M @ $XX /-3% $WVE 250M -350M @ $XX /-11% $FULC 150M- 175M @ $XXXX /-7% $DYN 300M -350M @ $XXXX / X% $VERA 200M -260M @ $XXXX /-7% $TERN 400M -650M @ $XX / -7%"
X Link 2025-12-10T13:26Z 6235 followers, 5119 engagements
"@TheBio_Hunter Agree. I should redo it from the max not from close Agree about $WVE. I would add $FULC and $TERN. Great data but too early to get really excited"
X Link 2025-12-10T14:25Z 6235 followers, XXX engagements
"$ABVX BO price is leaked- $XXX no CRV"
X Link 2025-12-10T15:09Z 6235 followers, 12.5K engagements
"$MDGL H.C.W. with new XXX PT These guys are typically reactive not proactive"
X Link 2025-12-11T17:42Z 6235 followers, 1671 engagements
"Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX"
X Link 2025-07-16T21:45Z 6240 followers, 42.6K engagements
"$CAPR No position but happy to see good jump after data. A lot of negativity before data kept me away Hope the same to repeat with $VTGN- a lot of negative posts and prediction for failure Hogh risk ph3 readout. Holding only Jan $X calls (no direct shares) to lower the risk"
X Link 2025-12-03T16:18Z 6237 followers, 1950 engagements
"$VKTX Todays FDA ruling about single trail requirement could speed up the drug approval process. Hope the pre-NDA FDA meeting will confirm that"
X Link 2025-12-05T01:37Z 6236 followers, 5172 engagements
"$KRYS Retweeting a post which got X like X retweet X reply Many missed the point that the PTD from FDA is a game changer making any future NDAs faster and with higher probability of approval And the stock is up 50%+ since then"
X Link 2025-12-05T18:21Z 6236 followers, 3137 engagements
"@physioo Thanks $KRYS is not a popular name Which is strange because it's text book investment for small investors- first and only treatment in something Plus HSV platform nobody even consider to develop Monopoly in its purest form"
X Link 2025-12-06T00:55Z 6236 followers, XXX engagements
"Capital raise of all winners today $KYMR 500M cash after that 1.1B $GPCR 500M cash after that 1.3B $WVE 250M cash after that 450M $FULC 150M cash after that 350M $NRIX no raise cash 430M So investors has to find 3B. Getting it from other bios We may have a few -ve days"
X Link 2025-12-08T21:44Z 6243 followers, 17.6K engagements
"Some missing companies or I didn't see them $AXSM $PRAX $ABVX $GPCR $CRNX $KURA $MIRM $CTYK"
X Link 2025-12-10T01:41Z 6241 followers, 7884 engagements
"@Tommy59737243 $ABEO 290M MC with 207M cash and cash flow positive in Q1'26 after 5M loss in Q3'25 Agree biotech is very difficult to invest🤣"
X Link 2025-12-11T14:40Z 6238 followers, XXX engagements
"$IMVT Capital raise 550M at $XX Delayed the TED data to q1 for strategic reason W/o too much speculations I know only one "strategic" reason for such delay And I'm not going to say what it is"
X Link 2025-12-11T18:05Z 6241 followers, 3390 engagements
"$KRYS Can you imagine there was a sell off after this ER to XXX on 10x avg volume It made me sweat bc it was my 5th position. Today is at ATH at XXX #2 in my port Happy that I didn't sell a single share"
X Link 2025-12-11T18:40Z 6243 followers, 1971 engagements
"@KingachillesE $CRNX great LT Hope all good with CAH OLE data. Efficacy and safety are great . except one case of elevated liver enzyme which resolved quickly. Still a red flag FDA didn't ask to change protocol just doing regular hepatic function test So cautiously optimistic"
X Link 2025-12-11T22:37Z 6240 followers, XXX engagements
"Darvin Global is buying $BLTE probably at the offering price XXX Good track record- $VRNA $MRYS $ABVX"
X Link 2025-12-12T13:51Z 6243 followers, 1918 engagements
"@monaco_biotech @bearsbounce With $ABVX they will make it X I think $BLTE is primed for BO as well Who would miss the opportunity to have oral Stargardt and potentially GA"
X Link 2025-12-12T13:57Z 6243 followers, 1081 engagements
"@PirateWaffle @long_biotech Well the first mover has a black box warning BTW outside of US is not zero - double digit on revenue w/o sales & any regulatory expenses $KURA doesn't need to raise cash until profitability. Soon w 1B cash $SNDX has 350M debt and only 450m cash. Capital raise is comming"
X Link 2025-12-12T15:39Z 6241 followers, XXX engagements
"$KYMR Closed the offering with 692M Baker Brothers bought 2.025M shares at $XX for 174M Now at #6 w market value $754M XXXX% ownership Strong vote of confidence in KYMR STAT6 degrader platform"
X Link 2025-12-13T01:34Z 6243 followers, 2345 engagements
"Plus $DYN 300M cash after that 1.1B $VERA 200M cash after that 700M Missing something"
X Link 2025-12-08T21:58Z 6242 followers, XXX engagements
"Botech in nutshell $ABVX (LP+C) from XX to XXX with good data $RZLT (NP) FROM XX to XXX at bad data"
X Link 2025-12-11T13:17Z 6242 followers, 9231 engagements
"$LLY Retatride data (triple G: GLP-1 + GIP + Glucagon (GCG) Good efficacy- XXXX% at 68w Knee osteoarthritis pain score reduced by XXX points (75.8%) Plus reduction in hsCRP non HDL and blood pressure Dream drug bud w/ tolerability issues - DC XX% $VKTX $GPCR"
X Link 2025-12-11T13:35Z 6243 followers, 2985 engagements
"$PPTA ATH at XX Hmm I wish smo would tell me to buy below XX Wait I actually did tell that to myself Not a biotech stock so just ignore"
X Link 2025-12-11T17:51Z 6243 followers, 1391 engagements
"$CRNX XX holla. The stock hit XX in Aug for some unknown reasons Focus next year is the acromegaly launch. It will be slow but steady. Be patient- endocrine drugs don't become blockbusters quickly. But eventually they will. Pipeline and events - see below"
X Link 2025-12-11T21:11Z 6243 followers, 3244 engagements
"@physioo I know. But did you ever ask yourself a question how it happened that companies like $ARGX $REGN $VRTX $GILD and such exist. Do you believe nobody wanted to buy them As a investor if I have smtg valuable I don't sell Not often but occasionally some CEOs have the same mentality"
X Link 2025-12-13T13:59Z 6243 followers, XXX engagements
"@physioo If they think that Crohn's is questionable they should sell It they trust the data - why nor wait. They can become next $ARGX BTW ARGX had 7B MC in 2020 w/ successful ph3 gMG approved in 2021- MC 18B Sales ramp - 30B CIDP approval 40B Today 56B Next ITP TED- 80B I can wait 5y"
X Link 2025-12-13T14:52Z 6243 followers, 8530 engagements
"$ABVX Everybody asking for BO but is it the best for us as investors They can be next $ARGX 12X since the ph3 gMG data in 2020 I can wait 5y for another 10x. I don't think $LLY can offer 50-60B and even if they do I would not take it"
X Link 2025-12-13T15:08Z 6243 followers, 8276 engagements